API Manufacturing · India · Est. 2016
Science at scale.
Quality without compromise.
Integrated API manufacturing and pharmaceutical contract manufacturing for partners who demand rigorous processes, responsive support and dependable delivery.
2011
R&D center founded
72 KL
Manufacturing capacity
WHO
GMP aligned
Adding to life care
An integrated API manufacturing partner — built on R&D, scale and an extremely skilled team.
From setting up an R&D center in 2011, our founder Jayantibhai Padsumbiya has helped Antique Healthcare grow into a vertically integrated API and bulk drugs manufacturing business with economies of scale.
Our skilled team enables timely delivery of quality products at affordable prices, and we foster excellence through innovation supported by strong R&D capabilities.
Every batch moves through our own active pharmaceutical ingredients production line, supported by dedicated API manufacturing infrastructure and quality and regulatory support, end to end.
Read our storyOur capabilities
Six disciplines, one operating standard.
01
Contract Manufacturing
Technologically oriented infrastructure and team offering CMO services to global pharmaceutical formulation partners.
02
Regulatory Expertise
Dossier maintenance and full documentation support, governed by our highest QA policies.
03
Quality Certified
Every product manufactured in a state-of-the-art facility, compliant with cGMP and WHO standards.
04
Customer Value
Creating and delivering tangible value is the first priority of our business and teams.
05
Operational Efficiency
In-house R&D for process optimization, scale up and large-scale cGMP production.
06
Quality of People
Our people — and the service they provide — are the measure of everything we ship.
Our work
Capabilities in action.
Kilo-to-Pilot Scale-Up
Moving a validated lab process into pilot and commercial-scale production without losing yield or purity.
Process Optimization for Niche APIs
In-house R&D refines every process for scale-up and large-scale cGMP production.
Cross-Functional R&D Collaboration
R&D, quality and production teams working from the same batch record, from lab bench to plant floor.
Our products
A growing API portfolio.
5 commercialized active pharmaceutical ingredients and 9 intermediates, across anticonvulsant, antibiotic, iron-replacement and anti-Alzheimer's therapeutic areas.
Gabapentin
CAS 181289-15-6
Nitrofurantoin
CAS 67-20-9
Ferric Carboxymaltose
CAS 9007-72-1
Rivastigmine Tartrate
CAS 129101-54-8
Key highlights
Built for stringent global standards.
- 01Dedicated analytical, micro and chemical labs
- 02Internationally recognized equipment qualification & change control
- 03Kilo and pilot scale facilities for cGMP synthesis of niche API
- 04Fully segregated RM and finished API warehousing
- 05Integrated R&D center for seamless technology transfer
- 06DMF, CTD and regulatory documentation
- 0727 reactors with a combined capacity of over 138 KL, plus dedicated hydrogenation autoclaves
- 08HVAC-controlled manufacturing per ICH guidelines
Leadership
Committed and experienced management.
Jayantibhai Padsumbiya
Founder
Sagar Kundariya
Chairman
Dr. Manish Shukla, PhD
Director, R&D
Responsibility
Committed to ESG excellence.
Responsible manufacturing means full compliance on paper. We hold ourselves to environmental, social and governance standards that protect our people and the planet.
Read our ESG commitments- 01
Environmental Stewardship
- 02
Access & Affordability
- 03
Equity, Diversity & Inclusion
- 04
Trust & Governance
FAQ
Answers to your manufacturing questions.
We manufacture a commercialized portfolio of active pharmaceutical ingredients and intermediates across anticonvulsant, antibiotic, iron-replacement and anti-Alzheimer's therapeutic areas. See our full product catalog for CAS numbers and specifications.
Yes. Our plant became a GMP-certified facility, and specific products such as Nitrofurantoin have received WHO-GMP approval. Manufacturing across the site follows cGMP- and WHO-compliant practices.
Yes. Our regulatory team develops DMFs, CTDs and other technical documents, and maintains dossiers to support customer regulatory submissions.
Our facility runs 27 reactors with a combined capacity of over 138 KL, plus dedicated hydrogenation autoclaves, and was recently upscaled to 72 KL of manufacturing capacity.
Yes. We offer CMO services backed by technologically oriented infrastructure, taking a process from kilo-lab development through pilot and commercial-scale production.
Get started
Schedule a manufacturing consultation.
Tell us about your requirement and our team will get back to you to discuss scope, scale and timelines.
Let's talk